Related Experiment Video

Updated: Jun 23, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

Correction for Van Gulck et al., "A truncated HIV Tat demonstrates potent and specific latency reversal activity"

Ellen Van Gulck, Marion Pardons, Erik Nijs

    Antimicrobial Agents and Chemotherapy
    |July 2, 2024
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
    07:10

    Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

    Published on: January 7, 2019

    High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
    07:18

    High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

    Published on: January 22, 2019

    Related Experiment Videos

    Last Updated: Jun 23, 2026

    A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
    14:23

    A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

    Published on: August 31, 2014

    Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
    07:10

    Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

    Published on: January 7, 2019

    High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
    07:18

    High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

    Published on: January 22, 2019

    Related Concept Videos

    Size and Structure of Viral Genomes01:26

    Size and Structure of Viral Genomes

    Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
    Inhibitors of Virion Maturation and Assembly01:19

    Inhibitors of Virion Maturation and Assembly

    As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...

    Articles linked to this work by shared authors, journal, and citation graph.

    A small-molecule SARS-CoV-2 inhibitor targeting the membrane protein.

    Nature·2025

    BET degraders reveal BRD4 disruption of 7SK and P-TEFb is critical for effective reactivation of latent HIV in CD4+ T-cells.

    Journal of virology·2025

    Non-AUG HIV-1 uORF translation elicits specific T cell immune response and regulates viral transcript expression.

    Nature communications·2025

    Unveiling conserved HIV-1 open reading frames encoding T cell antigens using ribosome profiling.

    Nature communications·2025

    Human Immunodeficiency Virus Impairs Immune Responses to Tumor Neoepitopes Without Altering Mutational Profiles in NSCLC.

    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2025

    The persistent pool of HIV-1-infected cells is formed episodically during untreated infection.

    Journal of virology·2024

    In vitro activity of zosurabalpin against a global set of carbapenem-resistant-A. baumannii clinical isolates.

    Antimicrobial agents and chemotherapy·2026

    N-terminal lysine as a critical determinant of odilorhabdin susceptibility to inactivation by the self-resistance acetyltransferase OatA.

    Antimicrobial agents and chemotherapy·2026

    Amphotericin B resistance in Lomentospora prolificans is associated with a soluble cell wall component.

    Antimicrobial agents and chemotherapy·2026

    Mechanistic blockade of RSV infection by a pre-F targeting single-domain antibody-Fc fusion protein.

    Antimicrobial agents and chemotherapy·2026

    High frequency of isavuconazole use over voriconazole for chronic pulmonary aspergillosis: a retrospective observational study on tolerability and therapeutic drug monitoring.

    Antimicrobial agents and chemotherapy·2026

    In vivo efficacy of cefiderocol against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa carrying the AmpC E219K substitution.

    Antimicrobial agents and chemotherapy·2026

    Outcomes of SGLT2 inhibitors after transcatheter mitral valve repair in patients with type 2 diabetes mellitus.

    Journal of cardiovascular medicine (Hagerstown, Md.)·2026

    A Case Report of Refractory Allergic Bronchopulmonary Aspergillosis: The Art of Selection, Discontinuation and Switching Biologics.

    Journal of inflammation research·2026

    APRIL-driven BCMA/TACI dual-targeted ligand-drug conjugates for selective and potent therapy of multiple myeloma.

    Acta pharmaceutica Sinica. B·2026

    Red light-responsive bioorthogonal chemistry enabled on-demand prodrug activation for cancer therapy.

    Acta pharmaceutica Sinica. B·2026

    Muscle Organoids and Organs-on-Chips: A 15-Year Global Bibliometric Perspective.

    Tissue engineering. Part B, Reviews·2026

    Allogeneic haematopoietic stem cell transplantation in late-onset metachromatic leukodystrophy.

    Brain : a journal of neurology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us